Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rangering i aksjer
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aksjekurs
$3.89
Markedsverdi
$3.30B
Endring (1 dag)
-3.14%
Endring (1 år)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategori
Healthcare
P/B-forhold for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
P/B-forhold per October 2026 TTM: 5.51
Ifølge Guangdong Zhongsheng Pharmaceutical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 5.51. Ved slutten av 2024 hadde selskapet et P/B-forhold på 2.58.
P/B-historikk for Guangdong Zhongsheng Pharmaceutical Co., Ltd. fra 2006 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 5.51 | 40.87% |
| 2025 | 3.91 | 51.53% |
| 2024 | 2.58 | -15.02% |
| 2023 | 3.04 | -48.28% |
| 2022 | 5.87 | 111.58% |
| 2021 | 2.77 | 10.44% |
| 2020 | 2.51 | 0.08% |
| 2019 | 2.51 | 56.81% |
| 2018 | 1.60 | -36.64% |
| 2017 | 2.53 | -7.85% |
| 2016 | 2.74 | -41.04% |
| 2015 | 4.65 | 23.59% |
| 2014 | 3.76 | -10.90% |
| 2013 | 4.22 | 19.35% |
| 2012 | 3.54 | 32.05% |
| 2011 | 2.68 | -31.18% |
| 2010 | 3.89 | 19.30% |
| 2009 | 3.26 | -89.60% |
| 2008 | 31.38 | -31.42% |
| 2007 | 45.75 | 8.30% |
| 2006 | 42.24 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| 1.9834 | -63.99% |
DE
|
|
| 2.1139 | -61.62% |
DE
|
|
| 1.3124 | -76.17% |
JP
|
|
| 6.3468 | 15.22% |
CH
|
|
| 5.0287 | -8.71% |
IN
|
